K-numberK241767
Device nameVersacem Acetabular Shell and Double Mobility HC Liners
ApplicantMedacta International S.A.
Product codeLZO
Device classClass II
Decision dateMar 6, 2025
DecisionSubstantially Equivalent
Regulation888.3353
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Versacem Acetabular Shell and Double Mobility HC Liners are sterile implantable devices used in total hip arthroplasty for primary or revision surgery. They are indicated for severely painful or disabled joints, avascular necrosis, traumatic fractures, and failed previous hip surgery, with particular use when dislocation prevention is critical and bone quality is poor. The device is intended for cemented use only.

Technological characteristics

The Versacem Acetabular Shell is a cemented semi-constrained metal/ceramic/polymer prosthesis available in sizes ∅40 to ∅56, compatible with Double Mobility HC Liners (including two new sizes ∅22.2/DMAZ and ∅28/DMC). Key characteristics include general design, articular surface, cementation method, material composition, biocompatibility profile, and packaging. Differences from the predicate include slight variations in size range, shelf-life, and sterilization method.

Test standards cited

ISO 11737-3 and European Pharmacopoeia §2.6.14 (bacterial endotoxin testing); USP <151> (in-vivo pyrogenicity in rabbit); USP chapters <85> and <161> (endotoxin quantification). Design validation, wear testing, range of motion evaluation, fatigue testing, pull-off and lever-out tests, jumping distance evaluation, and impingement risk assessment were conducted.

Substantial equivalence argument

The Versacem Acetabular Shell is substantially equivalent to the NOVAE Stick Dual Mobility Acetabular Cup predicate because both are cemented semi-constrained dual mobility hip prostheses with identical articular surfaces, materials, biocompatibility profiles, and intended use. Differences in size range, shelf-life, and sterilization method do not introduce new safety risks because bench testing validated performance across all sizes, the shelf-life is consistent with other cleared Medacta products, and the sterilization method is fully validated. The Double Mobility HC Liners are substantially equivalent to prior cleared versions because they maintain identical design, material, biocompatibility, and sterilization, with only outer diameter variation that does not affect performance as the inner diameter and articulation remain unchanged.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →